BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22728731)

  • 1. Char syndrome, a familial form of patent ductus arteriosus, with a new finding: hypoplasia [corrected] of the 3rd finger.
    Babaoğlu K; Oruç M; Günlemez A; Gelb BD
    Anadolu Kardiyol Derg; 2012 Sep; 12(6):523-4. PubMed ID: 22728731
    [No Abstract]   [Full Text] [Related]  

  • 2. Char Syndrome a novel mutation and new insights: A clinical report.
    Massaad E; Tfayli H; Awwad J; Nabulsi M; Farra C
    Eur J Med Genet; 2019 Dec; 62(12):103607. PubMed ID: 30579973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel missense mutation in TFAP2B associated with Char syndrome and central diabetes insipidus.
    Edward HL; D'Gama AM; Wojcik MH; Brownstein CA; Kenna MA; Grant PE; Majzoub JA; Agrawal PB
    Am J Med Genet A; 2019 Jul; 179(7):1299-1303. PubMed ID: 31012281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus.
    Satoda M; Zhao F; Diaz GA; Burn J; Goodship J; Davidson HR; Pierpont ME; Gelb BD
    Nat Genet; 2000 May; 25(1):42-6. PubMed ID: 10802654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of familial Char syndrome involving the TFAP2B gene with a focus on facial shape characteristics.
    Nyboe D; Kreiborg S; Darvann T; Dunø M; Nissen KR; Hove HB
    Clin Dysmorphol; 2018 Jul; 27(3):71-77. PubMed ID: 29683802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AP-2 Transcription Factor APTF-2 Is Required for Neuroblast and Epidermal Morphogenesis in Caenorhabditis elegans Embryogenesis.
    Budirahardja Y; Tan PY; Doan T; Weisdepp P; Zaidel-Bar R
    PLoS Genet; 2016 May; 12(5):e1006048. PubMed ID: 27176626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research progress of genetic research on Char syndrome].
    Zhao M; Fan L; Xiang R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Jun; 41(6):758-760. PubMed ID: 38818565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor AP-2beta in development, differentiation and tumorigenesis.
    Raap M; Gierendt L; Kreipe HH; Christgen M
    Int J Cancer; 2021 Sep; 149(6):1221-1227. PubMed ID: 33720400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial patent ductus arteriosus: a further case of CHAR syndrome.
    Slavotinek A; Clayton-Smith J; Super M
    Am J Med Genet; 1997 Aug; 71(2):229-32. PubMed ID: 9217229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TFAP2B mutation and dental anomalies.
    Tanasubsinn N; Sittiwangkul R; Pongprot Y; Kawasaki K; Ohazama A; Sastraruji T; Kaewgahya M; Kantaputra PN
    J Hum Genet; 2017 Aug; 62(8):769-775. PubMed ID: 28381879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel TFAP2B mutation in nonsyndromic patent ductus arteriosus.
    Khetyar M; Syrris P; Tinworth L; Abushaban L; Carter N
    Genet Test; 2008 Sep; 12(3):457-9. PubMed ID: 18752453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KCTD1 mutants in scalp‑ear‑nipple syndrome and AP‑2α P59A in Char syndrome reciprocally abrogate their interactions, but can regulate Wnt/β‑catenin signaling.
    Hu L; Chen L; Yang L; Ye Z; Huang W; Li X; Liu Q; Qiu J; Ding X
    Mol Med Rep; 2020 Nov; 22(5):3895-3903. PubMed ID: 33000225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further delineation of Char syndrome.
    Bertola DR; Kim CA; Sugayama SM; Utagawa CY; Albano LM; Gonzalez CH
    Pediatr Int; 2000 Feb; 42(1):85-8. PubMed ID: 10703243
    [No Abstract]   [Full Text] [Related]  

  • 14. Tfap2b mutation in mice results in patent ductus arteriosus and renal malformation.
    Wang J; Ji W; Zhu D; Wang W; Chen Y; Zhang Z; Li F
    J Surg Res; 2018 Jul; 227():178-185. PubMed ID: 29804851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Char syndrome (unusual mouth, patent ductus arteriosus, phalangeal anomalies).
    Temple IK
    Clin Dysmorphol; 1992 Jan; 1(1):17-21. PubMed ID: 1342853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of transcription factor AP-2 β mutations involved in familial isolated patent ductus arteriosus suggests haploinsufficiency.
    Ji W; Benson MA; Bhattacharya S; Chen Y; Hu J; Li F
    J Surg Res; 2014 May; 188(2):466-472. PubMed ID: 24507797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital corneal anesthesia with retinal abnormalities, deafness, unusual facies, persistent ductus arteriosus, and mental retardation: a new syndrome?
    Ramos-Arroyo MA; Clark GG; Saksena SS; Hodes ME
    Am J Med Genet; 1987 Feb; 26(2):345-54. PubMed ID: 2433942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndromic patent ductus arteriosus: evidence for haploinsufficient TFAP2B mutations and identification of a linked sleep disorder.
    Mani A; Radhakrishnan J; Farhi A; Carew KS; Warnes CA; Nelson-Williams C; Day RW; Pober B; State MW; Lifton RP
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2975-9. PubMed ID: 15684060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the pathogenesis and genetic background of patency of the ductus arteriosus.
    Bökenkamp R; DeRuiter MC; van Munsteren C; Gittenberger-de Groot AC
    Neonatology; 2010 Jun; 98(1):6-17. PubMed ID: 19955832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Char syndrome: an additional family with polythelia, a new finding.
    Zannolli R; Mostardini R; Matera M; Pucci L; Gelb BD; Morgese G
    Am J Med Genet; 2000 Nov; 95(3):201-3. PubMed ID: 11102923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.